Tag: Rituxan

FDA accepts review of Dr. Reddy’s biosimilar rituximab candidate, DRL_RI

businessnewstoday- July 12, 2023

Dr. Reddy's Laboratories, an Indian pharmaceutical company, announced that the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) for a ... Read More

Amgen, Allergan file BLA to FDA for Rituxan biosimilar ABP 798

pharmanewsdaily- December 20, 2019

Rituxan biosimilar ABP 798 : US biopharma company Amgen and Irish pharma company Allergan have submitted a Biologics License Application (BLA) to the US Food ... Read More